ABBV — AbbVie
Type: stock | Currency: USD | Sector: Health Care
Analysis update required
The stored signal has incomplete price provenance. It is shown only as historical information. ADD is the original model label, not a newly validated BUY.
Experimental technical research, not a fair-value assessment or personalized investment recommendation.
Stored assessment, historical plan and data provenance
Original action: ADD
Signal recorded at: 2026-11-18T07:56:37.019606+00:00
Data fetched at: N/A
Engine: N/A
Price basis: N/A
Technical score: N/A — not a probability
Why this assessment?
Fused signal based on technical setup and 10 recent news articles. News bias: 0.00, news strength: 0.30.
Time horizon: Days to weeks — fixed heuristic, not a forecast
Targets are stored technical levels, not estimates of intrinsic value. Previous stop/target events have not been integrated into this screen.
The temporary age rule flags prices more than three calendar days old. It is not exchange-calendar validation.
Calculation metadata
{}View scores, stored reasons and news
Latest stored ranking
Date: 2026-11-18
Stored rank: 74
Stored overall: 51.30
Model classification: watchlist
The overall score is experimental, not a fair-value estimate or investment recommendation.
Latest scores
Score date: 2026-11-18
Safety proxy: higher means better on the selected risk indicators; it does not measure total investment risk.
Heuristic value-trap flag: False
View full score breakdown and raw metrics
{
"risk": {
"leverage_score": 0.5,
"liquidity_score": 0.05833333333333329,
"volatility_score": 1.0
},
"value": {
"pb_score": 1.0,
"pe_score": 0.0,
"dividend_score": 1.0,
"ev_ebitda_score": 0.10950000000000004
},
"quality": {
"roe_score": 0.0,
"growth_score": 0.6866666666666666,
"margin_score": 0.7832999999999999
},
"raw_metrics": {
"beta": 0.192,
"ev_ebitda": 18.467,
"forward_pe": 18.055525,
"net_margin": 0.15666,
"trailing_pe": 50.573402,
"current_ratio": 0.87,
"price_to_book": -112.92712,
"debt_to_equity": null,
"dividend_yield": 2.35,
"revenue_growth": 0.103,
"operating_margin": 0.36635,
"return_on_equity": null
}
}
Latest active signal
Signal date: 2026-11-18T07:56:37.019606+00:00
Type: tactical
Action label: add
Model confidence: 65.00
Confidence is a heuristic model output, not a calibrated probability of profit.
Fused signal based on technical setup and 10 recent news articles. News bias: 0.00, news strength: 0.30.
Stored reasons
- news: Recent news is neutral or insufficiently influential | Technical confidence: 65.00 | News bias: 0.00 | News strength: 0.30 | Fused confidence: 65.00 | Recent articles analyzed: 10 | Previous technical action: add
- technical: Η τιμή είναι πάνω από SMA20 και SMA50 — bullish trend.
Latest stored news
-
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
Yahoo | 2026-11-18T01:47:02+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
How Did AbbVie's Neuroscience Franchise Perform in Q3?
Yahoo | 2026-11-17T19:03:00+00:00
Keyword sentiment: 0.33 | Keyword impact: 1.00 -
Invest $200,000 in These 5 Dividend Stocks to Fund Your Retirement Income
Yahoo | 2026-11-17T18:30:50+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
Yahoo | 2026-11-17T17:02:00+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
Cathie Wood and 9 Other Big Funds Bought Eli Lilly Last Quarter, While 18 Sold. Who’s Right?
Yahoo | 2026-11-17T16:53:51+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
J&J to Acquire Ollin Biosciences: A Look at Its Recent Buyouts
Yahoo | 2026-11-17T16:43:00+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
Yahoo | 2026-11-17T16:15:50+00:00
Keyword sentiment: -0.33 | Keyword impact: 1.00 -
Can Regeneron Stock Hit $1,400?
Yahoo | 2026-11-17T16:13:44+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
Should You Buy Pfizer Stock For Its Cash?
Yahoo | 2026-11-17T16:13:40+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00 -
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Yahoo | 2026-11-17T15:00:03+00:00
Keyword sentiment: 0.00 | Keyword impact: 0.00